Radiopharmaceutical therapy (RPT) is emerging as a safe and effective targeted approach
to treating many types of cancer. In RPT, radiation is systemically or locally delivered using …

Pheochromocytomas/paragangliomas are characterized by a unique molecular landscape
that allows their assignment to clusters based on underlying genetic alterations. With around …

Two different primary malignancies can arise from the adrenal gland: adrenocortical
carcinoma (ACC) from the adrenal cortex and malignant phaeochromocytoma from the …

Patients with metastatic or unresectable (advanced) pheochromocytoma and
paraganglioma (PPGL) have poor prognoses and few treatment options. This multicenter …

A molecular biology–based taxonomy has been proposed for pheochromocytoma and
paraganglioma (PPGL). Data from the Cancer Genome Atlas revealed clinically relevant …

The International Commission on Radiation Units and Measurements (ICRU), since its
inception in 1925, has had as its principal objective the development of internationally …

Two different primary malignancies can arise from the adrenal gland: the adrenocortical
carcinoma (ACC) from the adrenal cortex and the malignant pheochromocytoma from the …

This manuscript is the result of the North American Neuroendocrine Tumor Society
consensus conference on the medical management and surveillance of metastatic and …

Abstract Context Pheochromocytomas and paragangliomas (PPGLs) are believed to harbor
malignant potential; about 10% to 15% of pheochromocytomas and up to 50% of abdominal …

Purpose In this study, we aim to evaluate the efficacy and safety of 225 AC-DOTATATE
targeted alpha therapy in advanced-stage paragangliomas (PGLs). Methods Nine (6 males …